Please login to the form below

Not currently logged in

GE’s Fraser Black joins BioCity Scotland as MD

Replaces Ian Webster at Scottish life sciences hub

Fraser Black has been appointed as managing director at BioCity Scotland – a life sciences hub based at an old MSD facility in central Scotland.

He joins from GE Life Sciences where he was global services solutions director, and takes over from Ian Webster who had been managing director at BioCity Scotland since its launch in January, 2012.

In his new role, Black will oversee the collection of new bioscience and life sciences companies, including relationship-building with both corporate partners and the local community.

“In Newhouse, we have the resources and exceptional facilities to build a world class hub of successful life science businesses in the central belt of Scotland, and I believe the potential to add real value to the economy is enormous,” said Black. “This is the goal I will work towards as we collectively build the BioCity community here.”

Black had been at GE Life Sciences 2005 having previously held VP positions with Amersham Bioscience in both bioscience services and sales and marketing. He was also president of Hoefer Pharmacia Biotech.

“He brings business development experience honed in the international life sciences arena, as well as world-class team-building skills so we are in very good hands,” said Dr Louis Nisbet, BioCity Scotland chair.

9th July 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...